- Home
- MPAA vs LRMR Comparison
MPAA vs LRMR Comparison
Compare MPAA & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPAA
- LRMR
- Stock Information
- Founded
- MPAA 1968
- LRMR N/A
- Country
- MPAA United States
- LRMR United States
- Employees
- MPAA N/A
- LRMR N/A
- Industry
- MPAA Auto Parts:O.E.M.
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- MPAA Consumer Discretionary
- LRMR Health Care
- Exchange
- MPAA Nasdaq
- LRMR Nasdaq
- Market Cap
- MPAA 281.2M
- LRMR 309.8M
- IPO Year
- MPAA 1994
- LRMR N/A
- Fundamental
- Price
- MPAA $16.00
- LRMR $4.08
- Analyst Decision
- MPAA
- LRMR Strong Buy
- Analyst Count
- MPAA 0
- LRMR 7
- Target Price
- MPAA N/A
- LRMR $18.43
- AVG Volume (30 Days)
- MPAA 163.1K
- LRMR 1.3M
- Earning Date
- MPAA 11-11-2025
- LRMR 10-29-2025
- Dividend Yield
- MPAA N/A
- LRMR N/A
- EPS Growth
- MPAA N/A
- LRMR N/A
- EPS
- MPAA 0.08
- LRMR N/A
- Revenue
- MPAA $775,831,000.00
- LRMR N/A
- Revenue This Year
- MPAA $10.44
- LRMR N/A
- Revenue Next Year
- MPAA $4.88
- LRMR N/A
- P/E Ratio
- MPAA $200.82
- LRMR N/A
- Revenue Growth
- MPAA 6.59
- LRMR N/A
- 52 Week Low
- MPAA $5.16
- LRMR $1.61
- 52 Week High
- MPAA $16.59
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- MPAA 66.82
- LRMR 57.29
- Support Level
- MPAA $15.55
- LRMR $3.84
- Resistance Level
- MPAA $16.30
- LRMR $4.26
- Average True Range (ATR)
- MPAA 0.60
- LRMR 0.28
- MACD
- MPAA 0.05
- LRMR 0.00
- Stochastic Oscillator
- MPAA 75.21
- LRMR 71.10
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.